Clinical Drug Experience Knowledgebase

Carcinoma, Non-Small-Cell Lung

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Leukemia, Myeloid, Chronic-Phase

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Adenocarcinoma (Phase 2)

Adenocarcinoma of Lung (Phase 2)

Blast Crisis (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Endometrial Neoplasms (Phase 2)

Gastrointestinal Stromal Tumors (Phase 2)

Glioblastoma (Phase 1)

Glioma (Phase 1)

Gliosarcoma (Phase 1)

Hepatic Insufficiency (Phase 1)

Leiomyosarcoma (Phase 2)

Leukemia (Phase 3)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 3)

Liposarcoma (Phase 2)

Liver Failure (Phase 1)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 2)

Lymphoma, Large-Cell, Anaplastic (Phase 2)

Metaplasia (Phase 2)

Multiple Myeloma (Phase 1)

Myelodysplastic Syndromes (Phase 2)

Neoplasms (Phase 2)

Osteosarcoma (Phase 3)

Philadelphia Chromosome (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 2)

Primary Myelofibrosis (Phase 2)

Prostatic Neoplasms (Phase 2)

Sarcoma (Phase 3)

Small Cell Lung Carcinoma (Phase 2)

Syndrome (Phase 2)